Salvianolic acid B inhibits myofibroblast differentiation and extracellular matrix accumulation in nasal polyp fibroblasts via the TGF-β1 signaling pathway

Sun,Zhenfeng; Luo,Dan; Wang,Sang; Huang,Ruofei; Dong,Pin

doi:10.3892/mmr.2021.12117

Salvianolic acid B inhibits myofibroblast differentiation and extracellular matrix accumulation in nasal polyp fibroblasts via the TGF-β1 signaling pathway

Authors:
- Zhenfeng Sun
- Dan Luo
- Sang Wang
- Ruofei Huang
- Pin Dong
View Affiliations

Affiliations: Department of Otolaryngology, Head and Neck Surgery, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201620, P.R. China
Published online on: April 22, 2021 https://doi.org/10.3892/mmr.2021.12117
Article Number: 478

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the process of nasal tissue remodeling, nasal fibroblasts serve an important role via myofibroblast differentiation and the production of extracellular matrix (ECM). Nasal fibroblast abnormalities can lead to conditions such as chronic rhinosinusitis. Salvianolic acid B (Sal B), a water-soluble active pharmaceutical compound extract from the root of the traditional Chinese medicine Salvia miltiorrhiza, displays antioxidative, antiproliferative and antifibrosis properties. The present study aimed to investigate the mechanism underlying the effects of Sal B on nasal polyp fibroblast (NPF) myofibroblast differentiation and ECM accumulation. Primary NPFs were obtained from nasal polyps of patients with chronic sinusitis. The proliferative and cytotoxic effects of Sal B on NPFs were evaluated by performing the Cell Counting Kit-8 assay. The Transwell assay was conducted to assess cell migration. α-smooth muscle actin (α-SMA), TGF-β1 receptor (TβR)-I, TβR-II, Smad2/3 mRNA and protein expression levels and (p)-Smad2/3 phosphorylation levels were measured via reverse transcription-quantitative PCR and western blotting, respectively. Type III collagen and fibronectin levels were analyzed by ELISA. The results indicated that Sal B significantly downregulated TGF-β1-induced α-SMA, fibronectin and collagen III expression levels in NPFs. Similarly, Sal B significantly decreased TGF-β1-induced TβR-I, TβR-II, p-Smad2/3, MMP-2 and MMP-9 mRNA and protein expression levels in NPFs. Furthermore, Sal B significantly decreased TGF-β1-induced NPF migration. Therefore, the present study indicated that Sal B inhibited myofibroblast differentiation and ECM accumulation in nasal fibroblasts, suggesting that Sal B may inhibit nasal polyp formation via certain mechanisms.

View Figures

View References

1	Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I, Baroody F, Cohen N, Cervin A, Douglas R, Gevaert P, et al: European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 23:3 p preceding table of contents, 1. –298. 2012.PubMed/NCBI
2	Van Crombruggen K, Van Bruaene N, Holtappels G and Bachert C: Chronic sinusitis and rhinitis: Clinical terminology ‘Chronic Rhinosinusitis’ further supported. Rhinology. 48:54–58. 2010.PubMed/NCBI
3	Van Zele T, Holtappels G, Gevaert P and Bachert C: Differences in initial immunoprofiles between recurrent and nonrecurrent chronic rhinosinusitis with nasal polyps. Am J Rhinol Allergy. 28:192–198. 2014. View Article : Google Scholar : PubMed/NCBI
4	Pawankar R: Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol. 3:1–6. 2003. View Article : Google Scholar : PubMed/NCBI
5	Pezato R, Voegels RL, Pinto Bezerra TF, Perez-Novo C, Stamm AC and Gregorio LC: Mechanical disfunction in the mucosal oedema formation of patients with nasal polyps. Rhinology. 52:162–166. 2014. View Article : Google Scholar : PubMed/NCBI
6	Shin JM, Park JH, Kang B, Lee SA, Park IH and Lee HM: Effect of doxycycline on transforming growth factor-beta-1-induced matrix metalloproteinase 2 expression, migration, and collagen contraction in nasal polyp-derived fibroblasts. Am J Rhinol Allergy. 30:385–390. 2016. View Article : Google Scholar : PubMed/NCBI
7	Wang QP, Escudier E, Roudot-Thoraval F, Abd-Al Samad I, Peynegre R and Coste A: Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope. 107:926–931. 1997. View Article : Google Scholar : PubMed/NCBI
8	Shin SH, Ye MK, Lee DW and Che MH: Effect of Acacia Honey on Transforming Growth Factor-Beta-1-Induced Myofibroblast Differentiation and Matrix Metalloproteinase-9 Production in Nasal Polyp Fibroblasts. Am J Rhinol Allergy. 33:483–489. 2019. View Article : Google Scholar : PubMed/NCBI
9	Zhang L, Wu Z, Qin H, Chen W and Zhang G: Changes of Transforming Growth Factor-β1 and Extracellular Matrix in the Wound Healing Process of Rats Infected With Pseudomonas aeruginosa. Wounds. 26:293–300. 2014.PubMed/NCBI
10	Wang LF, Chien CY, Chiang FY, Chai CY and Tai CF: Corelationship between matrix metalloproteinase 2 and 9 expression and severity of chronic rhinosinusitis with nasal polyposis. Am J Rhinol Allergy. 26:e1–e4. 2012. View Article : Google Scholar : PubMed/NCBI
11	Watelet JB, Bachert C, Claeys C and Van Cauwenberge P: Matrix metalloproteinases MMP-7, MMP-9 and their tissue inhibitor TIMP-1: Expression in chronic sinusitis vs nasal polyposis. Allergy. 59:54–60. 2004. View Article : Google Scholar : PubMed/NCBI
12	Eyibilen A, Cayli S, Aladag I, Koç S, Gurbuzler L and Atay GA: Distribution of matrix metalloproteinases MMP-1, MMP-2, MMP-8 and tissue inhibitor of matrix metalloproteinases-2 in nasal polyposis and chronic rhinosinusitis. Histol Histopathol. 26:615–621. 2011.PubMed/NCBI
13	Can IH, Ceylan K, Caydere M, Samim EE, Ustun H and Karasoy DS: The expression of MMP-2, MMP-7, MMP-9, and TIMP-1 in chronic rhinosinusitis and nasal polyposis. Otolaryngol Head Neck Surg. 139:211–215. 2008. View Article : Google Scholar : PubMed/NCBI
14	Li X, Meng J, Qiao X, Liu Y, Liu F, Zhang N, Zhang J, Holtappels G, Luo B, Zhou P, et al: Expression of TGF, matrix metalloproteinases, and tissue inhibitors in Chinese chronic rhinosinusitis. J Allergy Clin Immunol. 125:1061–1068. 2010. View Article : Google Scholar : PubMed/NCBI
15	Kastrup J, Jørgensen E, Rück A, Tägil K, Glogar D, Ruzyllo W, Bøtker HE, Dudek D, Drvota V, Hesse B, et al Euroinject One Group, : Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: The Euroinject One trial. J Am Coll Cardiol. 45:982–988. 2005. View Article : Google Scholar : PubMed/NCBI
16	Jiang XW, Zhang Y, Yang SK, Zhang H, Lu K and Sun GL: Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol. 115:339–344. 2013. View Article : Google Scholar : PubMed/NCBI
17	Lin YL, Wu CH, Luo MH, Huang YJ, Wang CN, Shiao MS and Huang YT: In vitro protective effects of salvianolic acid B on primary hepatocytes and hepatic stellate cells. J Ethnopharmacol. 105:215–222. 2006. View Article : Google Scholar : PubMed/NCBI
18	Lv Z and Xu L: Salvianolic Acid B Inhibits ERK and p38 MAPK Signaling in TGF-β1-Stimulated Human Hepatic Stellate Cell Line (LX-2) via Distinct Pathways. Evid Based Complement Alternat Med. 2012:9601282012. View Article : Google Scholar : PubMed/NCBI
19	Lu HY, Zhou J, Lu M, Liu YM, Wang F, Lin M and Zhang Y: Protection and mechanisms of salvianolic-acid B on experimental renal interstitial fibrosis in rats. Zhong Yao Cai. 33:1755–1759. 2010.(In Chinese). PubMed/NCBI
20	Liu Q, Chu H, Ma Y, Wu T, Qian F, Ren X, Tu W, Zhou X, Jin L, Wu W, et al: Salvianolic Acid B Attenuates Experimental Pulmonary Fibrosis through Inhibition of the TGF-β Signaling Pathway. Sci Rep. 6:276102016. View Article : Google Scholar : PubMed/NCBI
21	Li Y, Wang L, Dong Z, Wang S, Qi L, Cho K, Zhang Z, Li N, Hu Y and Jiang B: Cardioprotection of salvianolic acid B and ginsenoside Rg1 combination on subacute myocardial infarction and the underlying mechanism. Phytomedicine. 57:255–261. 2019. View Article : Google Scholar : PubMed/NCBI
22	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−∆ ∆ C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
23	Cervin A: The anti-inflammatory effect of erythromycin and its derivatives, with special reference to nasal polyposis and chronic sinusitis. Acta Otolaryngol. 121:83–92. 2001. View Article : Google Scholar : PubMed/NCBI
24	Katainen E, Kostamo K, Virkkula P, Sorsa T, Tervahartiala T, Haapaniemi A and Toskala E: Local and systemic proteolytic responses in chronic rhinosinusitis with nasal polyposis and asthma. Int Forum Allergy Rhinol. 5:294–302. 2015. View Article : Google Scholar : PubMed/NCBI
25	Uluyol S, Arslan IB, Demir A, Mercan GC, Dogan O and Çukurova İ: The role of the uncinate process in sinusitis aetiology: Isolated agenesis versus maxillary sinus hypoplasia. J Laryngol Otol. 129:458–461. 2015. View Article : Google Scholar : PubMed/NCBI
26	Wang LF, Tai CF, Chien CY, Chiang FY and Chen JY: Vitamin D decreases the secretion of matrix metalloproteinase-2 and matrix metalloproteinase-9 in fibroblasts derived from Taiwanese patients with chronic rhinosinusitis with nasal polyposis. Kaohsiung J Med Sci. 31:235–240. 2015. View Article : Google Scholar : PubMed/NCBI
27	Park HH, Park IH, Cho JS, Lee YM and Lee HM: The effect of macrolides on myofibroblast differentiation and collagen production in nasal polyp-derived fibroblasts. Am J Rhinol Allergy. 24:348–353. 2010. View Article : Google Scholar : PubMed/NCBI
28	Mullol J, Roca-Ferrer J, Alobid I, Pujols L, Valero A, Xaubet A, Bernal-Sprekelsen M and Picado C: Effect of desloratadine on epithelial cell granulocyte-macrophage colony-stimulating factor secretion and eosinophil survival. Clin Exp Allergy. 36:52–58. 2006. View Article : Google Scholar : PubMed/NCBI
29	Cho JS, Moon YM, Park IH, Um JY, Moon JH, Park SJ, Lee SH, Kang HJ and Lee HM: Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts. Clin Exp Allergy. 42:872–882. 2012. View Article : Google Scholar : PubMed/NCBI
30	Um JY, Lee SA, Park JH, Shin JM, Park IH and Lee HM: Role of adenosine monophosphate-activated protein kinase on cell migration, matrix contraction, and matrix metalloproteinase-1 and matrix metalloproteinase-2 production in nasal polyp-derived fibroblasts. Am J Rhinol Allergy. 31:357–363. 2017. View Article : Google Scholar : PubMed/NCBI
31	Muluk NB, Arikan OK, Atasoy P, Kiliç R and Yalçinozan ET: The role of MMP-2, MMP-9, and TIMP-1 in the pathogenesis of nasal polyps: Immunohistochemical assessment at eight different levels in the epithelial, subepithelial, and deep layers of the mucosa. Ear Nose Throat J. 94:E1–E13. 2015.PubMed/NCBI
32	Suzuki M, Ramezanpour M, Cooksley C, Li J, Nakamaru Y, Homma A, Psaltis A, Wormald PJ and Vreugde S: Sirtuin-1 Controls Poly (I:C)-Dependent Matrix Metalloproteinase 9 Activation in Primary Human Nasal Epithelial Cells. Am J Respir Cell Mol Biol. 59:500–510. 2018. View Article : Google Scholar : PubMed/NCBI
33	Li X, Tao Y and Li X: Expression of MMP-9/TIMP-2 in nasal polyps and its functional implications. Int J Clin Exp Pathol. 8:14556–14561. 2015.PubMed/NCBI